We are live on ! Find out more
TGHSA

TPG Group Holdings (SBS) Advisors Portfolio holdings

AUM $10.1B
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+22.58%
3 Year Est. Return
+44.33%
5 Year Est. Return
+103.05%
10 Year Est. Return
AUM
$9.91B
AUM Growth
+$784M
Cap. Flow
-$517M
Cap. Flow %
-5.22%
Top 10 Hldgs %
81.14%
Holding
60
New
3
Increased
6
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$505M
2
UNF icon
Unifirst Corp
UNF
+$71.2M
3
PEGA icon
Pegasystems
PEGA
+$26.8M
4
UHS icon
Universal Health Services
UHS
+$14.6M
5
TV icon
Televisa
TV
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 50.26%
2 Healthcare 19.72%
3 Consumer Staples 5.91%
4 Real Estate 4.96%
5 Financials 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AERI
26
DELISTED
Aerie Pharmaceuticals
AERI
$46.7M 0.47%
1,237,466
EVH icon
27
Evolent Health
EVH
$371M
$41.8M 0.42%
1,698,300
-686,336
-29% -$16M
TFCF
28
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$41.2M 0.42%
1,664,436
-266,990
-14% -$6.96M
STZ icon
29
Constellation Brands
STZ
$22.5B
$40.9M 0.41%
245,856
-9,290
-4% -$1.53M
ALDR
30
DELISTED
Alder Biopharmaceuticals
ALDR
$40.6M 0.41%
1,238,533
OTIC
31
DELISTED
Otonomy, Inc.
OTIC
$39.3M 0.4%
2,159,335
XIN
32
DELISTED
Xinyuan Real Estate
XIN
$37.9M 0.38%
600,000
TV icon
33
Televisa
TV
$1.49B
$37.2M 0.38%
1,449,713
+518,603
+56% +$13.7M
NGVT icon
34
Ingevity
NGVT
$2.46B
$33.3M 0.34%
721,469
ATEX icon
35
Anterix
ATEX
$1.72B
$30.3M 0.31%
1,323,415
PEGA icon
36
Pegasystems
PEGA
$5.09B
$29.1M 0.29%
+1,972,790
New +$26.8M
VCYT icon
37
Veracyte
VCYT
$4.45B
$27M 0.27%
3,551,929
COLL icon
38
Collegium Pharmaceutical
COLL
$1.18B
$26.8M 0.27%
1,389,863
TMHC
39
DELISTED
Taylor Morrison
TMHC
$26.4M 0.27%
1,499,732
BEAV
40
DELISTED
B/E Aerospace Inc
BEAV
$22.7M 0.23%
440,365
+31,733
+8% +$1.53M
VRNT
41
DELISTED
Verint Systems
VRNT
$19.7M 0.2%
1,026,064
-1,406,566
-58% -$25.3M
TNDM icon
42
Tandem Diabetes Care
TNDM
$1.27B
$19.1M 0.19%
249,619
CBPX
43
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$15.1M 0.15%
718,592
-65,086
-8% -$1.46M
FLXN
44
DELISTED
Flexion Therapeutics, Inc.
FLXN
$14M 0.14%
714,285
WRK
45
DELISTED
WestRock Company
WRK
$11.1M 0.11%
227,977
-129,086
-36% -$5.76M
OXSQ icon
46
Oxford Square Capital
OXSQ
$150M
$9.51M 0.1%
1,633,719
+59
+0% +$346
XRM
47
DELISTED
Xerium Technologies Inc (new)
XRM
$9.4M 0.09%
1,182,878
GCVRZ
48
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5.46M 0.06%
20,240,462
CDNA icon
49
CareDx
CDNA
$1.83B
$3.82M 0.04%
1,075,090
AMRS
50
DELISTED
Amyris Inc.
AMRS
$2.31M 0.02%
265,244

Similar funds

TPG Group Holdings (SBS) Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, TPG Group Holdings (SBS) Advisors held 60 positions worth $9.91B, up 8.6% from $9.12B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

TPG Group Holdings (SBS) Advisors withdrew a net $517M in Q3 2016, closing 6 positions and reducing 16 holdings. Its most notable exit was Zimmer Biomet, an estimated $442M position sold in full.

By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 47% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, TPG Group Holdings (SBS) Advisors opened a new position in e.l.f. Beauty worth $543M.

  • TPG Group Holdings (SBS) Advisors's largest Q3 2016 buy was e.l.f. Beauty: 19,304,548 shares worth $543M.
  • TPG Group Holdings (SBS) Advisors added most to Universal Health Services in Q3 2016, an estimated $14.6M increase.
  • TPG Group Holdings (SBS) Advisors's biggest Q3 2016 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $43.5M.
  • TPG Group Holdings (SBS) Advisors fully exited Zimmer Biomet in Q3 2016, selling an estimated $442M.
  • TPG Group Holdings (SBS) Advisors's ten largest holdings make up 81% of its $9.91B portfolio in Q3 2016.
  • TPG Group Holdings (SBS) Advisors opened 3 new positions and closed 6 in Q3 2016.
  • TPG Group Holdings (SBS) Advisors's portfolio value rose 8.6% quarter-over-quarter to $9.91B.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.